Hernández-Álvarez E

Unit of Toxicology, Clinical Sciences Department, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.

8 papers · ORCID

ArticlePsychedelics

Understanding treatment expectations toward emerging therapies in veterinary medicine: the role of knowledge, attitudes, and beliefs toward psychedelic-assisted interventions.

Suárez-Fernández Y, Hernández-Álvarez E, Borkel LF +3

Europe PMC2026
ArticlePsychedelics

Attitudes toward psychedelic therapy among medical and nursing students: A cross-sectional survey study.

Castellano-Ramírez D, Hernández-Álvarez E, Borkel LF +3

Europe PMC2026
ArticleLSD

Evaluation of 1cp-LSD for Enhancing Welfare in Shelter Dogs: A Randomized Blind Trial with Ethological Intervention.

Hernández-Álvarez E, Canino-Quijada C, Roiz S +2

Europe PMC2026
ArticleLSD

Psychedelics as Novel Therapeutics for Chronic Pain in Veterinary Medicine: A Hypothesis-Driven Protocol Using Low-Dose 1-Cyclopropionyl-D-lysergic Acid Diethylamide (1cp-LSD) in Canine Osteoarthritis.

Hernández-Álvarez E, Acosta-Dacal A, Luzardo OP +1

Europe PMC2025
ArticleLSD

Preliminary Findings on Low-Dose 1cp-LSD for Canine Anxiety: Exploring the Role of Owner Neuroticism and Psychopathology.

Hernández-Álvarez E, Rojas-Hernández J, Borkel LF +3

Europe PMC2025
ArticlePsilocybin

The Causal Role of Consciousness in Psychedelic Therapy for Treatment-Resistant Depression: Hypothesis and Proposal.

Fernández-Borkel T, Borkel LF, Rojas-Hernández J +4

Europe PMC2025
ArticleLSD

Evaluating the Potential of Microdosing 1cp-LSD for the Treatment of Canine Anxiety: A One-Month Case Study.

Hernández-Álvarez E, Borkel LF, Rojas-Hernández J +5

Europe PMC2025
ArticleLSD

Single-dose 1cp-LSD administration for canine anxiety: a pilot study.

Henríquez-Hernández LA, García-Serrano I, Quintana-Hernández DJ +5

Europe PMC2024